ConductScience.org, home

Paper2016229

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

Aman MG and 4 others. J Am Acad Child Adolesc Psychiatry, 1991. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Papers, record 2016229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2016229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
PubMed
Journal
J Am Acad Child Adolesc Psychiatry
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
4.65
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aman MGM G
2Marks RER E
3Turbott SHS H
4Wilsher CPC P
5Merry SNS N

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Attention Deficit Disorder with HyperactivityMajor topic
Child Behavior DisordersMajor topic
Intellectual DisabilityMajor topic
MethylphenidateMajor topic
ThioridazineMajor topic
Adolescent
Attention
Child
Child, Preschool
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Male
Parents
Placebos
Teaching

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
35633446Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.J Autism Dev Disord2023https://conductscience.org/library/papers/35633446PubMed
32644833Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol2020https://conductscience.org/library/papers/32644833PubMed
29865900Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update.Can J Psychiatry2018https://conductscience.org/library/papers/29865900PubMed
27520752Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.CNS Drugs1997https://conductscience.org/library/papers/27520752PubMed
25886657
Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
Can J Psychiatry2015https://conductscience.org/library/papers/25886657PubMed
23133462Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum.J Can Acad Child Adolesc Psychiatry2012https://conductscience.org/library/papers/23133462PubMed
22899942Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome.Int J Pediatr2012https://conductscience.org/library/papers/22899942PubMed
18392193Pharmacotherapy of aggression in children and adolescents: efficacy and effect size.J Can Acad Child Adolesc Psychiatry2006https://conductscience.org/library/papers/18392193PubMed
15584771Pharmacotherapy of pervasive developmental disorders in children and adolescents.CNS Drugs2004https://conductscience.org/library/papers/15584771PubMed
11140783Medication treatment in subjects with autistic spectrum disorders.Eur Child Adolesc Psychiatry2000https://conductscience.org/library/papers/11140783PubMed
11140776Typical neuroleptics in child and adolescent psychiatry.Eur Child Adolesc Psychiatry2000https://conductscience.org/library/papers/11140776PubMed
10937459Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.Paediatr Drugs2000https://conductscience.org/library/papers/10937459PubMed
9711446Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.Drugs1998https://conductscience.org/library/papers/9711446PubMed
9304445Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD.J Abnorm Child Psychol1997https://conductscience.org/library/papers/9304445PubMed
8926223Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation.J Appl Behav Anal1996https://conductscience.org/library/papers/8926223PubMed
8347290Risks and benefits of drugs used in the management of the hyperactive child.Drug Saf1993https://conductscience.org/library/papers/8347290PubMed
1361998Management of psychopharmacologic agents in children and adolescents.Psychiatr Q1992https://conductscience.org/library/papers/1361998PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2016229

GET https://conductscience.org/api/papers/v1/2016229/authors